£4.3m boost for infectious Alderley-based healthtech
Summary
An Alderley-based healthtech company has secured a £4.3m funding boost to advance its infectious-disease-focused technology. The investment will support product development, clinical validation, and scaling of commercial operations. The company is likely to expand its team and accelerate go-to-market activities with the new capital. This funding highlights continued investor interest in healthtech solutions addressing infectious disease and strengthens the local innovation ecosystem.
Funding
Amount
$5.4M
Total raised
Date
May 13, 2026
Announcement date
Investors
GM&C Life Sciences Fund
Lead investors
Company
infextx.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected